MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts in New York City on Wednesday, November 5, 2014 at The Hudson Theatre at the Millennium Broadway, 145 West 44th Street, New York, NY.
During the event, Quest Diagnostics executives will discuss the company’s strategy, performance and plans to drive shareholder value.
Advance registration is required for those planning to attend in person. To register for the event, please go to the following website: register.questdiagnostics.com.
A live webcast of the event will be broadcast on the Investor Relations page of the Quest Diagnostics website. Additional information on accessing the webcast will be provided at a future date.
Quest Diagnostics is the world’s leading provider of diagnostic information services needed to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com.
Contacts:
Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
Logo - http://photos.prnewswire.com/prnh/20130717/NY48934LOGO
SOURCE Quest Diagnostics
Help employers find you! Check out all the jobs and post your resume.
